Loading...
01/10 17:29
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call showed positive financial performance with increased sales and gross profit, but ongoing net losses and rising SG&A expenses raise concerns. The lack of forward guidance and reliance on sales backlog add uncertainty. The Q&A section highlighted missed opportunities in data centers and unclear management responses. While there are positive trends, the absence of a share repurchase program and the dynamic market environment temper expectations. Overall, these factors suggest a neutral outlook for stock price movement.
Consolidated Net Sales Q2 2025 $17.5 million (up 8.9% year-over-year from $16.1 million); driven by increases in specialty markets.
Consolidated Net Sales Q1 2025 $15.7 million (up 11.5% sequentially); increases in both enterprise and specialty markets.
Consolidated Net Sales H1 2025 $33.3 million (up 7.5% year-over-year from $31 million); sales increases in both enterprise and specialty markets.
Gross Profit Q2 2025 $5.3 million (up 32.1% year-over-year from $4 million); improved manufacturing efficiencies and higher production volumes.
Gross Profit Margin Q2 2025 30.4% (up from 25.1% year-over-year and 29.4% sequentially); positively impacted by production efficiencies and operating leverage.
Gross Profit H1 2025 $10 million (up 28.5% year-over-year from $7.8 million); driven by production efficiencies and product mix.
Gross Profit Margin H1 2025 29.9% (up from 25% year-over-year); influenced by production efficiencies and product mix.
SG&A Expenses Q2 2025 $5.7 million (up from $5.3 million year-over-year); increase due to higher employee and contracted sales personnel-related costs.
SG&A as % of Net Sales Q2 2025 32.7% (down from 33% year-over-year and 34.7% sequentially); reflects improved sales performance.
Net Loss Q2 2025 $698,000 or $0.09 per share (improved from a net loss of $1.6 million or $0.21 per share year-over-year); reflects improved sales and gross profit.
Net Loss H1 2025 $1.8 million or $0.23 per share (improved from a net loss of $3 million or $0.39 per share year-over-year); driven by improved sales performance.
Sales Backlog: Sales backlog and forward load increased to $7.2 million compared to $6.6 million as of January 31, 2025, and $5.7 million as of October 31, 2024.
Gross Profit Margin: Gross profit margin increased to 30.4% in Q2 FY 2025, up from 25.1% in Q2 FY 2024.
Net Sales Growth: Consolidated net sales for Q2 FY 2025 increased 8.9% to $17.5 million compared to $16.1 million for the same period last year.
Production Efficiencies: Gross profit margin was positively impacted by production efficiencies created by higher volumes.
Growth Strategies: Focus on executing growth strategies and capitalizing on operating efficiencies to drive positive results.
Sales Growth: OCC experienced a net sales increase of 8.9% to $17.5 million in Q2 2025, but the stability of enterprise markets poses a risk to future growth.
Gross Profit Margin: Gross profit margin increased to 30.4% in Q2 2025, but is heavily dependent on product mix, which may vary and impact profitability.
SG&A Expenses: SG&A expenses rose to $5.7 million in Q2 2025, primarily due to increased employee and shipping costs, which could affect overall profitability.
Net Loss: OCC recorded a net loss of $698,000 in Q2 2025, indicating ongoing financial challenges despite improvements in sales and gross profit.
Market Dynamics: The company operates in a dynamic market environment, which presents uncertainties and competitive pressures that could impact future performance.
Sales Backlog: While the sales backlog increased to $7.2 million, reliance on this backlog for future revenue growth introduces risk if demand does not materialize.
Sales Backlog and Forward Load: Sales backlog and forward load increased to $7.2 million compared to $6.6 million as of January 31, 2025, and $5.7 million as of October 31, 2024.
Gross Profit Margin Expansion: Focus on executing growth strategies and capitalizing on operating efficiencies to drive positive results, including opportunities for gross profit margin expansion with increased production volume.
Market Trends: Positive industry trends are expected to benefit OCC as the year progresses.
Net Sales Growth: Consolidated net sales for Q2 FY 2025 increased 8.9% to $17.5 million compared to $16.1 million for the same period last year.
Gross Profit: Gross profit increased 32.1% to $5.3 million in Q2 FY 2025 compared to $4 million for the same period last year.
Net Loss: OCC recorded a net loss of $698,000 or $0.09 per share for Q2 FY 2025, an improvement from a net loss of $1.6 million or $0.21 per share for Q2 FY 2024.
First Half Financials: Consolidated net sales for the first half of FY 2025 were $33.3 million, an increase of 7.5% compared to $31 million for the first half of FY 2024.
Share Repurchase Program: None
The earnings call summary indicates optimism about future growth, particularly with the Lightera collaboration and data center markets. However, management's reluctance to provide guidance and specific financial metrics, coupled with no immediate impact from the collaboration, tempers the positive outlook. The Q&A section revealed no major negative trends but highlighted uncertainties in financial impact and project timelines. These mixed signals suggest a balanced market reaction, leading to a neutral sentiment rating for the stock price movement.
The earnings call summary highlights strong financial performance with an increase in net sales and gross profit, along with a reduced net loss. The Lightera partnership, despite limited details, is seen as a positive strategic move that could expand market opportunities and sales growth. The Q&A section did not uncover significant negative sentiment or risks. Overall, the financial improvements, partnership potential, and optimistic outlook suggest a positive stock price movement in the short term.
The earnings call showed positive financial performance with increased sales and gross profit, but ongoing net losses and rising SG&A expenses raise concerns. The lack of forward guidance and reliance on sales backlog add uncertainty. The Q&A section highlighted missed opportunities in data centers and unclear management responses. While there are positive trends, the absence of a share repurchase program and the dynamic market environment temper expectations. Overall, these factors suggest a neutral outlook for stock price movement.
The earnings call shows strong financial performance with increased net sales, gross profit, and a reduced net loss. The company is optimistic about future revenue and has improved its sales order backlog. While there are concerns about tariffs and competition, management does not expect significant negative impacts. The Q&A section reveals confidence in leveraging operating efficiencies and potential advantages from US manufacturing. Despite no share repurchase program, the overall sentiment is positive due to operational improvements and market potential, suggesting a stock price movement of 2% to 8%.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
